Header Logo
Last Name

Dr Adeagbo Babatunde

TitleLecturer I
InstitutionObafemi Awolowo University
DepartmentPharmaceutical Chemistry
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    I am a lecturer in the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria. I received my PhD in 2014, with the focus on population pharmacokinetics of imatinib mesylate. My research interest focus on development of bio-analytical assays and translational Pharmacokinetics, Pharmacogenomics and Pharmacometrics with emphasis on infectious diseases and cancer

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Olawoye OS, Adeagbo BA, Bolaji OO. Moringa oleifera leaf powder alters the pharmacokinetics of amodiaquine in healthy human volunteers. J Clin Pharm Ther. 2018 Oct; 43(5):626-632. PMID: 29920710.
      View in: PubMed
    2. Adehin A, Adeagbo BA, Kennedy MA, Bolaji OO, Olugbade TA, Bolarinwa RA, Durosinmi MA. Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients? Leuk Lymphoma. 2019 01; 60(1):216-221. PMID: 29741432.
      View in: PubMed
    3. Edema O, Adeagbo BA, Adehin A, Olugbade TA. Bidirectional Pharmacokinetic Interaction Between Amodiaquine and Pioglitazone in Healthy Subjects. J Clin Pharmacol. 2018 Apr 17. PMID: 29663414.
      View in: PubMed
    4. Adeagbo BA, Olugbade TA, Durosinmi MA, Bolarinwa RA, Ogungbenro K, Bolaji OO. Population Pharmacokinetics of Imatinib in Nigerians With Chronic Myeloid Leukemia: Clinical Implications for Dosing and Resistance. J Clin Pharmacol. 2017 Dec; 57(12):1554-1563. PMID: 28618035.
      View in: PubMed
    5. Izevbekhai O, Adeagbo B, Olagunju A, Bolaji O. Quality of artemisinin-based antimalarial drugs marketed in Nigeria. Trans R Soc Trop Med Hyg. 2017 02 01; 111(2):90-96. PMID: 28460126.
      View in: PubMed
    6. Adeagbo BA, Bolaji OO, Olugbade TA, Durosinmi MA, Bolarinwa RA, Masimirembwa C. Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia. J Clin Pharm Ther. 2016 Oct; 41(5):546-51. PMID: 27426203.
      View in: PubMed
    7. Olagunju A, Bolaji OO, Amara A, Waitt C, Else L, Soyinka J, Adeagbo B, Adejuyigbe E, Siccardi M, Back D, Owen A, Khoo S. Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. J Antimicrob Chemother. 2015 Feb; 70(2):555-61. PMID: 25326089.
      View in: PubMed
    Babatunde's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Physical Neighbors Expand Description